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Task sharing with non-physician health-care workers for 
management of blood pressure in low-income and 
middle-income countries: a systematic review and 
meta-analysis
T N Anand*, Linju Maria Joseph*, A V Geetha, Dorairaj Prabhakaran, Panniyammakal Jeemon
Summary
Background Task sharing for the management of hypertension could be useful for understaffed and resource-poor 
health systems. We assessed the effectiveness of task-sharing interventions in improving blood pressure control 
among adults in low-income and middle-income countries.
Methods We searched the Cochrane Library, PubMed, Embase, and CINAHL for studies published up to 
December 2018. We included intervention studies involving a task-sharing strategy for management of blood pressure 
and other cardiovascular risk factors. We extracted data on population, interventions, blood pressure, and task sharing 
groups. We did a meta-analysis of randomised controlled trials.
Findings We found 3012 references, of which 54 met the inclusion criteria initially. Another nine studies were included 
following an updated search. There were 43 trials and 20 before-and-after studies. We included 31 studies in our 
meta-analysis. Systolic blood pressure was decreased through task sharing in different groups of health-care workers: 
the mean difference was –5∙34 mm Hg (95% CI –9∙00 to –1∙67, I²=84%) for task sharing with nurses, –8∙12 mm Hg 
(–10∙23 to –6∙01, I²=57%) for pharmacists, –4∙67 mm Hg (–7∙09 to –2∙24, I²=0%) for dietitians, –3∙67 mm Hg 
(–4∙58 to –2∙77, I²=24%) for community health workers, and –4∙85 mm Hg (–6∙12 to –3∙57, I²=76%) overall. We 
found a similar reduction in diastolic blood pressure (overall mean difference –2∙92 mm Hg, –3∙75 to –2∙09, I²=80%). 
The overall quality of evidence based on GRADE criteria was moderate for systolic blood pressure, but low for diastolic 
blood pressure.
Interpretation Task-sharing interventions are effective in reducing blood pressure. Long-term studies are needed to 
understand their potential impact on cardiovascular outcomes and mortality.
Funding Wellcome Trust/DBT India Alliance.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Low-income and middle-income countries (LMICs) bear 
a disproportionately large burden of cardiovascular 
disease, and have fewer resources to address it.1 
Hypertension, an important risk factor for cardiovascular 
disease, contributes to more than 10% of disability-
adjusted life-years lost in LMICs.2 Large randomised 
controlled trials and prospective observational studies 
show the benefits of achieving optimal blood pressure 
control for reducing mortality and cardiovascular out-
comes.3 However, despite the availability of effective 
therapies, blood pressure control rates are poor in many 
LMICs.4
LMICs are undergoing an epidemiological transition 
from predominantly infectious diseases, maternal and 
child-health conditions, and nutritional disorders to 
chronic non-communicable diseases such as diabetes and 
hypertension.5 With a rising burden of non-com municable 
disease, health-policy makers have deliberated the merits 
of delegating or moving certain tasks from physicians to 
other health-care professionals, through task shifting or 
task sharing.6 Task shifting is defined as the rational 
movement of primary care duties from physicians to 
non-physician health-care workers, such as nurses, 
pharmacists, or community health workers.7 Task sharing 
is a planned strategy in which a team of health-care 
professionals work together to deliver a service, 
accompanied by training or certification and support for 
health-care workers.8,9 Task sharing is considered a more 
appropriate term than task shifting in highly skilled areas 
because it is difficult to shift tasks entirely to new cadres of 
health-care workers.10 However, the two terms indicate 
slightly different scenarios. When there is no physician 
available, the tasks must be shifted to non-physician 
health-care workers for the health system to function. 
When a few physicians are available, tasks may be shared 
with other health-care professionals with some supervision 
or referral to physicians.10 In LMICs, where access to and 
availability of physicians can be difficult, utilising the 
available non-physician health-care workforce may be a 
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logical step for the management of cardiovascular risk. 
Task sharing in LMICs has been useful in managing 
maternal and child health11 and communicable diseases 
such as HIV/AIDS.12
Primary and secondary prevention of hypertension, 
often involve lifestyle counselling, adoption of self-
management skills, and the implementation of protocol-
led treatment can be instituted by non-physician 
health-care workers.13 A Cochrane review14 demonstrated 
that care led by a nurse or pharmacist could be a 
favourable way of improving blood pressure control in 
patients with hypertension, but most of the evidence 
comes from high-income countries. Such interventions, 
specifically conducted in LMICs, require further evalu-
ation as effectiveness depends on health system capacity 
and adaptability. We did a systematic review and meta-
analysis of task-sharing interventions and their effects on 
managing blood pressure in LMICs.
Methods
Search strategy and selection criteria
We developed a search strategy based on a previous 
review15 and modified the terms according to the 
database. We searched PubMed, Embase, Cochrane 
Library, and CINAHL with terms related to cardiovascular 
disease, task sharing, and LMICs (appendix pp 46–53). 
The search covered the period from inception of each 
database to Aug 15, 2017. We did an updated search up to 
Dec 28, 2018. We also manually searched the reference 
lists of identified studies.
We included experimental studies (randomised con-
trolled trials, cluster randomised trials, quasiexperimental 
studies, and before-and-after designs) that included 
interventions delivered by community health workers, 
nurses, pharmacists, and allied health professionals such 
as dietitians, designed to improve blood pressure control 
regardless of hypertension status. For the purpose of our 
review, the tasks shared included non-pharmacological 
measures such as patient education for lifestyle 
modification and pharmacological measures such as 
initiation or refill of prescription medications and 
titrating the dose of medications. Other measures, such 
as follow-up and patient reminders for referrals and 
appointments were also included. The population of 
interest was adults aged 18 or older, living in LMICs, 
regardless of their hypertension status.
We did not include studies in which non-physician 
health-care workers only screened for hypertension. We 
also excluded studies with patient’s knowledge, attitudes, 
or intentions as outcome variables without measuring 
any relevant blood pressure outcomes. Peer-led inter-
ventions were excluded because they would be more 
likely to involve informal support. Additionally, we 
excluded studies of task-sharing activities that are 
exclusive to traditional healers, alternative therapies such 
as acupuncture, homoeopathic medicine, and those of 
only the promotion of self-care or informal caregiver 
health education.
Furthermore, we excluded studies without before and 
after measurements of blood pressure, and studies that 
included fewer than 30 participants or less than 3 months 
of follow-up from the meta-analyses. Studies with no or 
insufficient description of randomisation were also 
excluded from the meta-analyses. We also excluded studies 
that were not in English.
Our study was registered in the PROSPERO database 
(CRD42018081015). Ethical approval was not required.
Data analysis
Initially, duplicates were removed and the remaining 
citations were reviewed by one author (JLM) based first 
on the titles to obtain relevant records for abstract 
Research in context
Evidence before this study
We searched PubMed, Cochrane Library, Embase, and CINAHL 
without any language restrictions for studies published up to 
Aug 31, 2017, that described task-sharing interventions for 
managing blood pressure. We later updated our search to 
December 2018. Our search terms were related to task sharing 
and cardiovascular diseases combined with a list of low-income 
and lower-middle income countries as defined by the World Bank. 
We identified two reviews of task-sharing interventions for 
non-communicable diseases. One described the effectiveness of 
non-physician health-care workers involved in prescription of 
medications for cardiovascular risk reduction, while the other 
described enablers and barriers for task-sharing interventions. 
The reviews show that task sharing is a potentially viable and 
low-cost strategy for understaffed low-income and lower-middle 
income countries. We found no published meta-analyses of 
task-sharing interventions for managing blood pressure.
Added value of this study
Our meta-analysis shows that task-sharing interventions are 
effective in reducing average blood pressure in low-income and 
lower-middle income countries. Our results validate the 
possibility of using task sharing for non-communicable disease 
prevention and management in these settings. However, the 
impact of task-sharing interventions is greater in countries with 
better doctor:population ratios. Additionally, we show that 
interventions are more effective if targeted to high-risk 
individuals than to the general population.
Implications of all the available evidence
Involving non-physician health-care workers in blood pressure 
control is an effective option in low-income and lower-middle 
income countries.
See Online for appendix
Articles
www.thelancet.com/lancetgh   Vol 7   June 2019 e763
screening. All selected abstracts were screened manually 
and identified relevant articles for full text review by JLM 
and ATN. Two authors (LMJ and TNA) independently 
reviewed full texts of all selected studies for final 
inclusion in the review. Any disagreements were resolved 
by discussion with a third reviewer (PJ).
Data were extracted when available from published 
articles. Study authors were contacted twice for data if 
the outcome of interest was not made available in the 
published studies. Study quality was assessed in terms of 
potential bias from randomisation, blinding, outcome 
assessment, and method of analysis using the Cochrane 
Risk of bias tool16 and National Heart Lung and Blood 
Institute scale17 for before-and-after studies.
Two researchers (LMJ and TNA) cross-checked study 
details, summary measures, and major outcomes against 
the published articles. The arbitrator (PJ) reviewed any 
apparent inconsistencies and made the final recom-
mendation. Blood pressure measurements (in mm Hg) 
that were done before and after the intervention, for both 
intervention and control groups, were extracted. We also 
extracted data for study design, unit of analysis, sample 
size, study population, task-sharing group, year, author, 
follow-up duration, country of origin, and intervention 
details. The main outcomes of interest were changes in 
systolic and diastolic blood pressure compared with 
baseline.
Statistical analysis
We conducted meta-analysis of randomised controlled 
trials that had at least 30 participants in each group. 
Although cluster randomised trials were included in 
the analysis, we estimated effective sample sizes for 
each study based on their respective design effect.18 
Design effect was calculated from the reported intraclass 
correlation coefficient and average cluster size of 
corresponding studies. Details of the design effect 
calculation are given in the appendix (pp 53–54).
Net blood pressure was calculated on the basis of the 
difference between the mean blood pressure of the 
experimental and control groups. We adopted the inverse 
variance method for developing weights for individual 
study effects. We quantified heterogeneity using I² and 
Q statistics.19 We used a random effect model to assess the 
population average mean difference and 95% CI of both 
systolic and diastolic blood pressure according to the task-
sharing groups. To assess each study’s contribution 
towards overall heterogeneity, we conducted a sensitivity 
analysis by subsequently adding studies and noting 
the change in heterogeneity. In order to measure the 
dispersion of the pooled effect across study settings, 
we generated predictions intervals.20 We did exploratory 
subgroup analyses of the length of interventions, study 
participant characteristics, physician density in the coun-
try, and sample size, for estimating any potential 
difference in the pooled average effect of intervention on 
blood pressure. Individual study effects and pooled effects 
were visualised through forest plots. Publication bias was 
assessed graphically through funnel plot asymmetry and 
statistically by Egger’s regression test.21 Data were pooled 
and analysed using “meta” package of R (version 3.5.1).22 
Quality of the evidence was evaluated using GRADE 
criteria.23
Role of the funding source
There was no funding for this study. The corresponding 
author had full access to all the data in the study and 
had final responsibility for the decision to submit for 
publication.
Results
We identified a total of 3012 references from our searches 
(figure 1). After removing 162 duplicates, we screened 
the titles of 2850, 2279 of which were excluded. We 
screened 571 abstracts and identified 86 potentially 
eligible articles. Another four studies were included 
after manually searching. The full texts of 90 studies 
were reviewed and 36 were excluded. Thus, we included 
54 studies. An updated hand search and database search 
done up to December, 2018, identified an additional nine 
eligible studies. Thus, 63 studies were included in the 
narrative review and 31 studies (trials) were included in 
the meta-analyses.
Of the 63 studies included in the review, there were 
32 randomised controlled trials (from 33 publications),24–56 
11 cluster randomised trials,57–67 and 20 before-and-after 
studies68–87 (appendix pp 3–38). 50 studies were done in 
Asia and Africa. Studies mostly took place in the 
community (n=15), primary health centres (n=24), out-
patient clinics (n=16), and hospitals (n=8). Interventions 
were delivered by nurses (n=30), pharmacists (n=10), 
dietitians (n=4), and community health workers (n=19). 
We included 31 studies with 13 489 participants in the 
meta-analyses. Individual study sizes ranged from 35 to 
3977 participants. 16 studies lasted 12 months or more. 
The nature of the interventions varied. We categorised 
them into lifestyle modifications through education for 
participants, follow-up care, algorithm-based manage-
ment, non-physician drug prescription, referrals, and 
organisation of care.
We assessed the quality of trials using the Cochrane 
risk of bias tool (appendix p 34). Four studies41,49,51,56 did 
not mention randomisation methods and the randomi-
sation method was unclear in five studies.24,25,27,36,59 
Only 15 of 43 trials reported details of allocation 
concealment.29,32,35,36,39,45–47,50,53,55,63–67 Two studies29,30 reported 
participant blinding and 14 studies25,26,29,40,44,46,50–53,55,66 
reported outcome assessor blinding.
We included 43 trials and 20 before-and-after studies 
for narrative synthesis. Most of the trials recruited 
participants with hypertension (n=16), another ten 
recruited patients with diabetes, eight with cardiovascular 
disease (two of which were in patients who had had a 
stroke), five from the general population, two with 
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overweight or metabolic syndrome, one with post-acute 
coronary syndrome, and one with dyslipidaemia. The 
interventions were facilitated by nurses (n=21), dietitians 
(n=4), pharmacists (n=7), and community health workers 
(n=11).
Education about lifestyle modifications was a component 
of the intervention in most studies (41 [95%] of 43), 
including education on diet (n=31), physical activity 
(n=25), and reducing smoking (n=13) and alcohol 
consumption (n=8). Two studies26,44 began health education 
at hospital and continued at home, after discharge from 
hospital. Hacihasanoğlu and colleagues41 did a three group 
trial, with a control group who received usual care, an 
intervention group who received health education on 
medication adherence, and another group who received 
education about medical adherence, diet, and importance 
of physical activity. Two studies42,46 used nurses trained in 
motivational inter viewing to involve participants in 
identifying problems, setting goals, and creating action 
plans to modify health. Pharmacist-led studies included 
monitoring of drug-related problems (such as changes in 
blood pressure or side-effects) in addition to lifestyle 
counselling.31,39,49
Home visits were part of the intervention in ten 
studies.24,26,41,44,47,48,53,56,58,64 Home visits were made to impart 
or reinforce lifestyle education and for home blood 
pressure monitoring. Two studies52,64 used community 
health workers to monitor blood pressure at participants’ 
homes, and another two41,56 used nurses to monitor blood 
pressure at home. Labhardt and colleagues36 used 
reminder letters for missed appointments by participants.
Seven studies tested algorithm-based manage-
ment.38,45,59,61,62,65,66 Ali and colleagues,45 Tian and colleagues,62 
and Prabhakaran and colleagues66 implemented algorithm-
based disease management by using an electronic decision 
support system. Four studies59,61,62,65 tested a treatment 
algorithm and automatic decision prompt to initiate 
prescriptions of hypertension drugs.
Seven studies46,48,54,62–66 tested a referral system for 
participants with high or uncontrolled blood pressure. In 
two studies,62,64 community health workers referred 
patients to health-care facilities for anti-hypertensive 
drugs. Goudge and colleagues63 used community health 
workers to assist nurses in organising care such as 
booking appointments and telephoning with reminders 
for participants with hypertension. Ogedegbe and 
colleagues65 referred patients with high cardiovascular 
risk to hospital for further management.
Six of 43 randomised controlled trials did not report 
the outcome variable of interest (difference in blood 
pressure before and after the intervention). Additionally, 
four studies were excluded because of inadequate 
description of randomisation procedure, one study was 
excluded because it was a feasibility trial with less than 
3 months of follow-up, and another one was excluded 
because of differences in task sharing (involving 
non-blood pressure drug titrations across multiple 
therapeutic areas). Finally, 31 trials were included in the 
meta-analyses (including two groups from Azami and 
colleagues’ study55 and three groups from Neupane and 
3012 records identified through database searching
2850 screened by titles
162 duplicates removed
2279 excluded
 924 other diseases
 512 biochemical and genetic studies
 843 animal studies, caregiver perspectives,
  other interventions
4 identified through citation and reference search
9 identified from updated search
571 screened by abstracts
485 excluded
 75 not task shifting intervention
 57 not conducted in LIMICs
 60 relevant outcomes not reported
 23 provider knowledge perception
 13 caregiver perceptions
 37 telemedicine, SMS CHW training
 10 other languages
 63 protocol, review, qualitative studies
 48 cross sectional studies
 22 no CVD
 33 programme evaluation
 16 guidelines
 28 reviews
90 eligible full texts screened
36 excluded
 8 not done in LIMIC
 5 protocol only
 3 cross-sectional studies
 1 retracted
 2 abstracts
 3 screening only
 11 no relevant BP outcomes
 3 cost-effective models
63 studies included in qualitative synthesis
31 included in meta-analysis of systolic BP
28 included in meta-analysis of diastolic BP
32 excluded
 4 potential serious risk of bias
 1 substantially different task shifting
  strategy
 20 non-RCT study design
 6 absence of pre-post outcome data
 1 substantially lower follow-up time
Figure 1: Literature search and article inclusion
SMS=short messaging service. CHW=community health worker. CKD=chronic kidney disease. LMIC=low-income 
and middle-income country. CVD=cardiovascular disease. SBP=systolic blood pressure. DBP=diastolic blood 
pressure. RCT=randomised controlled trial.
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colleagues’ study64). In the meta-analyses only ran-
domised controlled trials and cluster randomised 
controlled trials were included.
The population average mean difference between before 
and after measurements of systolic blood pressure ranged 
from –3∙67 mm Hg (95% CI –4∙58 to –2∙77, I²=24%; for 
interventions delivered by community health workers) to 
–8∙12 mm Hg (–10∙23 to –6∙01, I²=57%; for interventions 
delivered by pharmacists). Dietitians delivering the 
intervention resulted in an average mean difference 
of –4∙67 mm Hg (–7∙09 to –2∙24; I²=0%), and when 
nurses delivered the intervention it was –5∙34 mm Hg 
(–9∙00 to –1∙67; I²=84%; figure 2). Overall, the average 
mean difference in systolic blood pressure was 
–4∙85 mm Hg (–6∙12 to –3∙57; I²=76%). The prediction 
interval for the systolic blood pressure pooled estimate 
was –11∙03 to 1∙33. Funnel plots for publication bias did 
not show any asymmetry (appendix p 36) and the Egger’s 
regression test did not indicate bias (t=0∙12, degrees of 
freedom=32, p value=0∙90). We found a similar reduction 
in diastolic blood pressure (overall mean difference 
–2∙92 mm Hg, –3∙75 to –2∙09, I²=80%). The average 
mean difference of diastolic blood pressure ranged from 
–2∙29 to –3∙74 mm Hg, depending on the task sharing 
group (figure 3). The prediction interval of the diastolic 
blood pressure pooled average estimate ranged from 
–6∙90 to 1∙06. We found no evidence of bias for diastolic 
blood pressure in funnel plots (appendix p 37) or from 
Figure 2: Systolic blood pressure changes with task sharing compared with usual care
Weight
(%)
Experimental
Total Mean SD
Control Mean difference (95% CI)
Total Mean SD
0–10–20 10 20
Dietitian 
Muchiri
Ali
Goldhaber-Fiebert
Sartorelli
Random effects model
Heterogeneity: I2=0%, τ2=0, p=0·65 
Community health worker    
Mash
Xavier
Jafar
Mendis I
Mendis II
Tian
He
Chao
Neupane (Normo)
Neupane (Pre HTN)
Neupane (HTN)
Cappuccio
de Souza
Random effects model
Heterogeneity: I2=24%, τ2=0·5873, p=0·21 
Nurse   
Saffi
Jiang
Zhu
Jayasuriy
Cakir
Ma
Zhang
Ogedegbe
Sarfo
Azami
Prabhakaran
Random effects model
Heterogeneity: I2=84%, τ2=27·6749, p<0·01 
Pharmacist
Hammad 
Jarab
Zhao
Plaster
Wal
Sookaneknun
Random effects model
Heterogeneity: I2=57%, τ2=3·6648, p=0·04 
Random effects model
Prediction interval
Heterogeneity: I2=76%, τ2=8·7772, p<0·01 
41
575
33
40
689
175
375
269
256
250
1095
709
957
197
81
118
168
62
4712
38
83
67
28
30
54
100
157
16
71
331
975
110
77
129
34
54
118
522
6898
−1·80
−18·30
−5·00
−0·80
2·90
0·30
−5·60
−13·28
−11·01
−11·80
−19·30
−5·60
4·39
0·42
−6·47
−1·30
−4·00
−12·00
1·18
−14·72
−1·70
−8·90
−11·36
−14·10
−19·80
−9·00
−2·90
−15·90
−12·10
−5·80
−8·50
−7·00
−30·70
−23·29
29·45
25·43
23·00
12·30
32·93
22·60
32·15
12·25
15·37
27·90
19·01
15·03
9·11
8·84
16·23
26·20
22·00
26·15
18·58
20·02
17·09
5·20
20·83
11·30
21·16
24·30
9·20
16·65
20·10
11·64
16·45
3·50
10·42
17·46
 41
 571
 28
 31
671
 145
 375
 266
 258
 255
 991
 648
1005
 141
 58
 83
 169
 56
4450
 
 36
 84
 67
 25
 30
 52
 99
 166
 16
 71
 333
 979
 89
 79
 129
 29
 48
 117
 491
6591
−3·30
−12·90
−4·00
3·10
8·90
2·70
−6·60
−9·42
−6·61
−9·10
−12·70
−1·65
6·61
2·88
−2·85
1·80
1·00
3·00
2·67
−9·22
6·00
1·20
−3·55
−4·40
−16·50
−7·50
−0·60
−18·40
−6·90
1·10
−1·90
3·00
−18·46
−17·64
33·59
23·16
16·00
13·00
34·55
24·39
32·29
11·77
20·57
27·50
18·18
12·48
9·82
10·69
19·63
25·75
23·00
21·89
20·16
19·89
18·01
5·30
19·99
14·25
21·19
20·55
12·15
16·65
14·60
5·89
16·71
3·50
9·63
18·91
1·50
−5·40
−1·00
−3·90
−4·67
−6·00
−2·40
1·00
−3·86
−4·40
−2·70
−6·60
−3·95
−2·22
−2·46
−3·62
−3·10
−5·00
−3·67
−15·00
−1·49
−5·50
−7·70
−10·10
−7·81
−9·70
−3·30
−1·50
−2·30
2·50
−5·34
−5·20
−6·90
−6·60
−10·00
−12·24
−5·65
−8·12
–4·85
(−12·17 to 15·17)
(−8·22 to −2·58)
(−10·83 to 8·83)
(−9·86 to 2·06)
(−7·09 to −2·24)
(−13·45 to 1·45)
(−5·77 to 0·97)
(−4·46 to 6·46)
(−5·94 to −1·78)
(−7·56 to −1·24)
(−5·08 to −0·32)
(−8·58 to −4·62)
(−5·18 to −2·72)
(−4·28 to −0·16)
(−5·82 to 0·90)
(−8·76 to 1·52)
(−8·65 to 2·45)
(−13·14 to 3·14)
(−4·58 to −2·77)
(−25·97 to −4·03)
(−7·37 to 4·39)
(−12·26 to 1·26)
(−17·18 to 1·78)
(−12·76 to −7·44)
(−15·58 to −0·04)
(−13·28 to −6·12)
( −7·92 to 1·32)
(−17·09 to 14·09)
(−5·84 to 1·24)
(−0·03 to 5·03)
(−9·00 to −1·67)
(−10·03 to −0·37)
(−9·81 to −3·99)
(−10·65 to −2·55)
(−11·73 to −8·27)
(−16·13 to −8·35)
(−10·30 to −1·00)
(−10·23 to −6·01)
(−6·12 to −3·57)
(−11·03 to 1·33)
0·7
3·9
1·2
2·4
8·3
1·8
3·6
2·6
4·3
3·7
4·1
4·3
4·6
4·3
3·6
2·7
2·5
1·6
43·9
1·1
2·4
2·1
1·3
4·0
1·7
3·5
3·0
0·6
3·5
4·1
27·2
2·9
3·9
3·3
4·4
3·3
2·9
20·7
100·0
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Egger’s regression test (t=–0∙365, degrees of freedom=29, 
p value=0∙71).
Subgroup analyses demonstrated larger systolic blood 
pressure responses in high-risk individuals (individuals 
with diabetes mellitus, coronary artery disease, or 
hypertension) compared with interventions implemented 
in the general population (appendix p 38). Similar 
differences were also observed for the average mean 
difference in diastolic blood pressure, but the mean 
diastolic blood pressure differences were higher in 
coronary artery disease and diabetes populations 
(appendix p 39). Studies of patients with hypertension, 
studies of pharmacist-led interventions, and studies with 
smaller sample size had larger reductions in both systolic 
and diastolic blood pressure (appendix pp 39–43). 
Additionally, blood pressure response was greatest in 
studies with short follow-up compared with studies 
with medium or long follow-up (appendix pp 40–41). In 
general, blood pressure reductions were better in smaller 
trials (n<500) than in larger trials (n>500; appendix 
pp 42–43). Blood pressure changes were largest in 
settings with more physicians (appendix pp 44–45).
Due to considerable heterogeneity, we did an 
exploratory sensitivity analysis by using the leave-one-
study-out method. The exclusion of two studies32,66 
reduced the overall I² from 76∙3% to 57∙3% for systolic 
blood pressure. Excluding these two studies from the 
analysis of diastolic blood pressure caused a small 
reduction in overall I² (from 79∙5% to 71∙3%), with 
little change in the population average: systolic blood 
pressure change was –4∙92 mm Hg and diastolic blood 
pressure change was –3∙10.
Figure 3: Diastolic blood pressure changes with task sharing compared with usual care
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In total, 20 before-and-after design studies were 
included in the review and results are summarised 
descriptively. There were three studies each from 
Cameroon,73–75 India,70,76,82 and Thailand,71,72,84 two each 
from Iran,77,85 Guatemala,80,86 and Nigeria,69,88 and one each 
from Honduras,78 Ghana,83 Mexico,79 and South Africa.68 
One multicentre study was done in Bangladesh, Pakistan, 
and Sri Lanka.81 Three studies,76,77,79 recruited participants 
from the general population, whereas all other studies 
were conducted in high-risk participants such as 
individuals with hypertension, diabetes mellitus, and 
cardiovascular disease. Similar to randomised controlled 
trials, the intervention tasks were shared with nurses, 
pharmacists, health promotion specialist, and com-
munity health workers. All the included studies used life-
style modification education for the participants. Group 
and individual life-style education were used. In one 
study,86 life-style education was delivered in a series of 
home visits. The content of life-style education varied 
from diet (n=15), physical activity (n=9), and medication 
adherence (n=6) among studies. 11 studies69,76–81,84–86 
delivered life-style education alone for managing blood 
pressure, eight of which reported a reduction in blood 
pressure following the lifestyle intervention. However, 
three studies77,79,84 did not show a reduction in blood 
pressure,77,84 or found an increase in blood pressure 
among elderly participants.79
Most of the studies had a clear objective and eligibility 
criteria reported (appendix 22–28). However, whether 
participants were representative of the clinical population 
was difficult to determine because of unclear reporting of 
recruitment methods in nine studies. All studies 
described the intervention but none reported blinding of 
outcome assessors. Sample size calculations were 
reported in six studies,70,71,79,83,84,87 statistical pre-post tests 
were done in 19 studies, and 14 studies68,70,72–75,77–79,81,82,84,86,87 
adjusted for potential confounders.
Four studies70,72,80,84 had follow-up interventions for 
management of blood pressure. Two studies each 
employed nurses72,84 and community health workers54,64 
for follow up. Navichraren and colleagues84 telephoned 
participants following life-style education classes but 
reported no difference in blood pressure. Other studies 
used home visits to impart life-style modification edu-
cation. A study done in India70 used cardiovascular 
disease risk profiling and referral to physicians along 
with follow-up by community health workers to 
reinforce risk reduction and adherence to treatment. It 
showed a significant fall in systolic blood pressure of 
8∙8 mm Hg. Similarly, a study done in Guatemala80 had 
nurse-led cardiovascular risk management and follow-
up by community health workers, resulting in a mean 
reduction of 27∙2 mm Hg for systolic blood pressure 
and 7∙7 mm Hg for diastolic blood pressure. Suwanphan 
and colleagues72 arranged for six consecutive monthly 
home visits, but found no statistically significant 
improvements in blood pressure.
All the studies using protocol-based care showed a 
reduction in blood pressure. In a multicountry study81 the 
overall mean systolic blood pressure decreased by 
4∙5 mm Hg (95% CI 2∙3 to 6∙7). Two studies in which 
community health-care workers delivered the inter vention 
also resulted in reduction in mean systolic blood pressure 
(by 8∙8 mm Hg in one study,70 27∙2 mm Hg in another80). 
In one study,82 nurse care coordinators used a clinical 
decision support system on a mobile phone to generate a 
prescription, which was vetted by a physician, which 
reduced systolic blood pressure by 14∙6 mm Hg (95% CI 
15∙3 to 13∙8) and diastolic blood pressure by 7∙6 mm Hg 
(8∙0 to 7∙2). In South Africa,68 68% of patients with 
hypertension achieved blood pressure control through 
a stepwise process of diagnosis, management, and 
appropriate referral. Although the three Cameroonian 
studies73–75 reported statistically significant reductions in 
mean blood pressure (of 11∙7/7∙8 mm Hg, 
5∙9/3∙3 mm Hg, and 22∙8/12∙4 mm Hg), they had high 
drop-out rates. In a study done in Nigeria,87 pharmacy staff 
had regular consultations with patients for blood pressure 
measurements and lifestyle counselling (with the help of an 
mHealth application and under the supervision of a 
cardiologist) and achieved a mean reduction of 9∙9 mm Hg 
(SD 18) in systolic blood pressure.
In three studies from Cameroon, nurses could 
prescribe medicines, which resulted in meaningful 
reductions in average blood pressure (11∙7/7∙8 mm Hg 
in one study,73 5∙9/3∙3 mm Hg in another,74 and 
22∙8/12∙4 mm Hg in a third75). In two other studies,68,80 
nurses could prescribe first-line hypertension drugs. 
However, in cases of newly diagnosed hypertension or in 
individuals with high cardiovascular risk, nurses had to 
seek advice from physicians before initiating treatment. 
Both studies showed a significant reduction in blood 
pressure. Ajay et al82 tested the effects of nurse care 
coordinators using a clinical decision support system on 
a mobile phone to generate a prescription that was vetted 
by a physician and showed a 14∙6 mm Hg (95% CI 
15∙3 to –3∙8) reduction in systolic blood pressure and a 
7∙6 mm Hg (95% CI 8∙0 to 7∙2) reduction in diastolic 
blood pressure.
Nine studies68,70,74,75,80–83,87 tested arrangements for long-
term organised care in which a nurse or community 
health worker referred participants to a physician or 
health-care facility. Organisation of care ranged from 
coordination of groups for education, appointment 
reminders, medication dispensing, screening for cardio-
vascular disease risk, and referral for further treatment. 
However, the effectiveness of arrangements for follow-up 
on patient outcomes was not assessed specifically.
In terms of study quality, the evidence for task-sharing 
interventions to lower systolic blood pressure delivered 
by nurses, pharmacists, and community health workers 
was classed as moderate because of indirectness and 
inconsistency. The evidence for managing diastolic blood 
pressure was rated as low because of both indirectness 
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and inconsistency. We did not downgrade studies for lack 
of masking because implementation of task-sharing 
interventions in real life is unlikely to be masked.
Discussion
We systematically reviewed the effectiveness of task-
sharing interventions for managing blood pressure in 
LMICs and identified studies involving nurses, dietitians, 
pharmacists, and community health workers. Overall, 
task-sharing interventions led to reduction in average 
blood pressure levels. Although the prediction intervals 
indicate variation in blood pressure responses across 
study settings, the interpretation of prediction intervals 
are compromised when study sizes vary.88 Our analyses 
indicate that the blood pressure response is lowest in 
settings where the density of physicians is lowest. 
However, in settings with higher physician density, even 
within LMICs, we found better blood pressure responses. 
Despite the moderate-to-high heterogeneity in the pooled 
results, the overall quality of evidence was moderate for 
systolic blood pressure, and low for diastolic blood 
pressure on GRADE criteria.
Healthy life-style education was the mainstay of most of 
the interventions studied. Although all types of non-
physician health workers were involved in delivery of the 
intervention, the effectiveness was relatively better when 
given by workers with more education such as nurses and 
pharmacists. The higher order groups of workers were 
involved in activities such as protocol-based care, decision 
support systems for screening, stratification, triage, and 
medication adherence monitoring in addition to life-style 
education. A review of task-shifting by Ogedegbe and 
colleagues89 found that involving non-physician health-
care workers such as nurses in prescribing of medications, 
treatment, or medical testing significantly improved blood 
pressure and glucose levels. Task-sharing interventions 
should be designed with an understanding of the specific 
health service delivery context. WHO provides a framework 
and global recommendations for task sharing from 
medical doctors to nurses and community health workers 
for HIV/AIDS care in low-resource settings.7 Nurses or 
pharmacists can take referrals from community health 
workers for basic anti-hypertensive medication 
prescriptions or titration of medications, thus leaving 
physicians to care for complex cases. The range of task-
sharing strategies implemented in a study in Ghana might 
be an ideal example,65 where nurses are engaged in 
cardiovascular risk screening, life-style counselling, and 
initiation or titration of hypertension medications. A 
Cochrane review90 showed that nurse-led or pharmacist-led 
care could effectively improve blood pressure control. 
There fore, it is essential to have policies on collaborative 
care models that involve non-physician prescriptions and 
organisation of health-care service for better task sharing 
in low-income and high-income countries.
All of the community health worker-led intervention 
studies included in our review focused on life-style 
education mainly at home or in community settings. 
Community health workers in LMICs are engaged in 
health promotion activities in reproductive health and 
family planning and they conduct regular home visits in 
their assigned areas. It is therefore practically possible for 
them to also support non-communicable disease 
prevention in home and community settings. Further-
more, engaging community health workers in cardio-
vascular screening in low-resource settings is considered 
as a cost-effective strategy for averting mortality.91 A 
structured group education programme92 delivered by 
mid-level trained health-care workers at community 
health centres in South Africa has been found to be both 
effective in reducing blood pressure and cost-effective.
Prior studies91,93 have shown that community health 
workers with adequate training can successfully screen 
for blood pressure and other cardiovascular risk factors. 
However, screening for risk factors should be adequately 
supported by lifestyle education, basic prescription of 
drugs, and proper referral for managing complex 
conditions. Referrals to primary care centres were 
increased due to community health worker interventions 
in several studies.63,81 However, these primary care centres 
face shortages of drugs, failure of equipment, and 
insufficient physician time due to increased patient load. 
Along with task sharing it is therefore important to 
increase access to medicines for better blood pressure 
control.
Task sharing without health system strengthening, 
restructuring, and health-care regulation will not yield 
any desirable results.94 Several studies62,66,82,87 demonstrated 
that care led by nurses and pharmacists with electronic 
decision support systems and algorithms can manage 
blood pressure effectively. However, to successfully 
implement these measures across a health system, in-
service training, supportive supervision, and expansion 
of job descriptions will be needed. Incorporating 
dietitians or nutritionists into public health systems for 
prevention and management of non-communicable dis-
eases should be explored further. Additionally, future 
studies should evaluate the role of collaborative care in 
engaging different cadres of the health workforce simul-
taneously in prevention and control of hypertension.
Many of the interventions studied were multifaceted. In 
some studies, a care coordinator, aided by an electronic 
decision support system, acted as a link between patients 
and physicians for better blood pressure control and other 
risk factor management. This approach has a component 
of both mHealth and task sharing for managing multiple 
risk factors simultaneously. Although the relative 
effectiveness of the individual components has not been 
evaluated, there is some evidence90 that multiple risk 
factor interventions might lower blood pressure. He and 
colleagues52 and Jafar and colleagues81 also reported 
multicomponent interventions in which the strategies 
were cumulatively effective in reducing blood pressure. 
Fairall and colleagues61 tested task sharing for a range of 
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conditions such as diabetes, hypertension, chronic 
respiratory disease, and depression. Such integrated 
disease management strategies are essential to improve 
delivery of care for chronic diseases. A systematic review95 
investigated the effectiveness of integrated care and 
found that patient access to services was largely improved 
compared with routine care.
Although studies with long-term follow-up demonstrate 
the effectiveness of task sharing for reducing blood 
pressure, the effect was moderate as compared with 
short-term follow-up studies. Maintenance of healthy 
behaviours for the entire follow-up period might require 
sustained efforts. Long-term follow-up studies should 
also focus on evaluating the effectiveness of interventions 
in reducing clinically relevant patient-oriented outcomes 
such as mortality and quality of life.
Strengths of the review included a comprehensive 
search strategy in multiple databases. The inclusion of 
different study designs enabled us to review different 
types of intervention for managing blood pressure. We 
have incorporated studies irrespective of participants’ 
hypertension status. Our review has limitations. We did 
not categorically identify the influence of each 
intervention method on blood pressure control. However, 
we analysed the treat ment effects based on intervention 
providers, treatment, or follow-up duration. The strength 
of the overall quality of evidence was hampered due to 
potential bias resulting from unclear randomisation, 
allocation concealment, and blinding, and improper 
analysis in cluster randomised trials. We excluded the 
study by Fairall and colleagues61 because of considerable 
differ ences from the rest of the studies. It deals with task-
sharing to authorise prescription of an expanded range of 
drugs such as enalapril and amlodipine for hyper tension, 
glibenclamide and gliclazide for diabetes, and simvastatin 
for increased cardiovascular risk. Lastly, we might have 
missed studies not published in English.
In conclusion, task-sharing interventions for managing 
hypertension in LMICs show potential in reducing blood 
pressure. However, further implementation research is 
needed to understand the implications for health systems 
and patient-oriented outcomes. Future research should 
focus on ascertaining how the interventions fare in 
community settings. Implementation research such as 
nurse-led hypertension management in western Kenya96 
might show further usefulness of task sharing. How 
health-care teams and systems can ensure continuity of 
task-sharing interventions should also be investigated. 
Future studies should also include information regarding 
the health workforce available. Assessing the cost 
effectiveness of task-sharing interventions, such as done 
in Argentina,97 will aid decision making. Understanding 
barriers and facilitators of scale up in diverse settings 
should also be studied. Policies to enable wider 
implementation of task-sharing interventions for control 
of blood pressure along with other risk factors for non-
communicable diseases are needed.
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